LoQus23
LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases
LoQus23 Offices
OnSite Workspace
Employees work from physical offices.
Typical time on-site:
None
London, England
